Ultra-Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Ultra-Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Cancer (HYPO-RT-PC): Patient-Reported Quality-of-Life Outcomes of a Randomised, Controlled, Non-Inferiority, Phase 3 Trial
Lancet Oncol 2021 Jan 11;[EPub Ahead of Print], P Fransson, P Nilsson, A Gunnlaugsson, L Beckman, B Tavelin, D Norman, C Thellenberg-Karlsson, M Hoyer, M Lagerlund, J Kindblom, C Ginman, B Johansson, K Björnlinger, M Seke, M Agrup, B Zackrisson, E Kjellén, L Franzén, A WidmarkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.